Written and maintained by CASRAI Editorial Board
Last updated
AdisInsight (also written Adis Insight) is a drug development and clinical research database from Adis International Ltd., part of Springer Nature. It tracks drug and cell-based products in commercial development worldwide, together with the clinical trials, safety reports, deals and patents connected to them.
For translational researchers, clinical trialists and medical affairs professionals, the database is one input for reading the global drug pipeline. It sits alongside regulatory affairs in the pharmaceutical industry work and the sponsor relationships described in the pharmaceutical CRO industry sector overview.
What it is
AdisInsight is a curated intelligence platform that follows drugs from discovery to launch across all therapeutic areas. Its official content description says it combines drug profiles with the trials, safety reports, deals and patents attached to each product, so a researcher can move between them for one asset.
When drafting a clinical trial protocol design, teams can use the trial profiles to see how comparable programs set phases, endpoints and eligibility criteria.
Who runs it and what it covers
The platform is published by Adis International Ltd., part of Springer Nature; the copyright holder shown on the site is Springer Nature Switzerland AG. Its content is organised into five areas:
- Drugs: profiles that cover development milestones and status, drug properties, chemical synopses, pharmacokinetic and pharmacodynamic data, company agreements, trials, related safety reports, patents and related drugs.
- Trials: international and observational trials, with phase and status, purpose and design, endpoints, diseases and subjects, eligibility criteria, identifiers, organizations, dates, interventions, investigators and outcomes.
- Safety Reports: safety intelligence built from automated content acquisition plus expert human validation, with keywords normalized to the Adis thesaurus and a first-pass triage step that estimates how likely an article is to be an Individual Case Safety Report (ICSR).
- Deals: purchases, acquisitions, joint ventures, and licensing, R&D, manufacturing, distribution and marketing agreements, with agreement type, date, organizations, drugs, indications, summary and deal value where available.
- Patents: global patents and market exclusivities that protect a drug, shown in summary tables to help determine the timing of generic entry.
How safety reports are classified
Safety Reports sort each source article into one of these labels:
- ADR Category 1: the source explicitly or strongly suggests an association between a named drug and an adverse reaction in at least one identifiable patient.
- ADR Category 2: the source suggests a possible drug-event association or safety concern but lacks sufficient detail.
- ADR Category 3: safety-relevant context without a specific drug-event pair, such as risk factors, mechanisms or class-wide warnings.
- Special Situation: no ADR in the categories above, but involving use during pregnancy or breastfeeding, off-label use, overdose, abuse, misuse, medication error, occupational exposure or lack of therapeutic efficacy.
- News: items selected and summarized by Adis editors from case reports, regulatory agencies, scientific meetings and media releases.
How to search or use it
AdisInsight is a subscription product, and its pages sit behind a Springer Nature sign-in. Within it, the five content areas above are the main ways in: look up a drug to see its development status, trials, safety reports, deals and patents together, or start from the Trials content to compare study designs and endpoints. For enterprise analytics, the Drugs and Trials datasets are also offered on Snowflake (through a “Request on Snowflake” link to the Snowflake Marketplace listing), and the Snowflake page states that they mirror the content available through the AdisInsight APIs. Details of the interface, training and account setup are in the platform’s own help pages, which require sign-in.
For related tooling, see the guide to clinical data management tools and the guide to BioMedTracker, a separate pipeline-tracking product.
Strengths and limits
Strengths:
- Expert validation of safety content, with a defined ADR category scheme.
- Drugs, trials, safety reports, deals and patents are linked in one place for each asset.
- Snowflake datasets suit analytics and enterprise data integration.
Limits:
- It is a commercial, sign-in product, so access usually depends on an institutional or company subscription.
- It covers drugs and cell-based products in commercial development; it is not a general literature index.
Alternatives
| Platform | What it is |
|---|---|
| AdisInsight | Curated drug development database from Adis International Ltd. (Springer Nature) covering drugs, trials, safety reports, deals and patents. |
| ClinicalTrials.gov | Public registry of clinical study records, where sponsors and investigators submit registration and results information. |
| BioMedTracker | Commercial pipeline-tracking product; see the BioMedTracker guide. |
FAQ
What is AdisInsight?
A curated database from Adis International Ltd., part of Springer Nature, covering drugs and cell-based products in development worldwide, plus their trials, safety reports, deals and patents.
Is Adis Insight the same as AdisInsight?
Yes. “Adis Insight” is a common spelling of the same platform.
How does AdisInsight classify adverse drug reaction reports?
Into ADR Category 1, 2 and 3, plus Special Situation and News, as described under “How safety reports are classified” above.
Who publishes AdisInsight?
Adis International Ltd., part of Springer Nature.
Can AdisInsight data be used outside the web application?
The Drugs and Trials datasets are offered on Snowflake for analytics and enterprise integration, according to the platform’s Snowflake page.
Sources
- AdisInsight, About Our Content. Adis International Ltd, Springer Nature. https://adisinsight.springer.com/aboutourcontent. Checked: 2026-11-07.
- AdisInsight Datasets via Snowflake. Springer Nature. https://adisinsight.springer.com/datasets-snowflake. Checked: 2026-11-07.
- ClinicalTrials.gov, About the site. https://clinicaltrials.gov/about-site/about-ctg. Checked: 2026-11-07.
